search
Back to results

Website-Based Self-Help for Women With Anxiety After Childbirth

Primary Purpose

Anxiety Disorders

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
internet-What Am I Worried About
Sponsored by
City, University of London
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anxiety Disorders focused on measuring Anxiety, Anxiety disorders, Mental health, Postpartum period, maternal welfare, internet, intervention studies, feasibility studies, randomized controlled trial, patient acceptance of health care

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Women who are within the first 12 months postpartum (at the beginning of the intervention)
  • Aged over 18
  • Living in England
  • Sufficient knowledge of written and spoken English
  • Access to internet at home
  • Report a score of ≥5 on the Generalized Anxiety Disorder Scale (GAD-7; Spitzer, Kroenke, Williams, & Löwe, 2006)

Exclusion Criteria:

  • Still birth or perinatal death of latest baby
  • Latest baby seriously ill
  • Report self-harm or suicidal ideation
  • Currently receiving formal psychotherapy

Sites / Locations

  • City, University of London
  • City University of London

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Web-based intervention

Wait-list control

Arm Description

Participants get access to the web-based intervention and are asked to work through the 8 modules of the intervention within eight weeks. The intervention program sends automated weekly email reminders about the current session. In addition, users are offered weekly optional 30-minute telephone support with a trained intervention coach.

Participants get standard care and will be offered access to the web-based intervention at 8-weeks post-randomization.

Outcomes

Primary Outcome Measures

Engagement as measured by the number of log-ins into the web-based intervention
Engagement as measured by the duration of log-ins into the web-based intervention
Engagement as measured by the total duration of time spent on the web-based intervention
Engagement as measured by the time spent on individual pages of the web-based intervention
Engagement as measured by the number of intervention coach calls
Usability as measured by participant's report of usefulness ("I found this module useful.") of each intervention module on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Usability as measured by participant's report of clarity ("This module was clear and understandable.") of each intervention module on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Usability as measured by participant's report of usability on the System Usability Scale (SUS)
The System Usability Scale (SUS) is a 10-item instrument rated on 5-point Likert scale (1 = strongly disagree to 5 = strongly agree) and participants are asked to rate the degree to which they agree with positive and negative descriptions of a program. The SUS will be adapted for this study by replacing 'the system/product' with 'iWAWA' for all items. Higher scores indicate better usability.
Usability as measured by participant's report of usability on a series of items designed to measure ease-of-use and unobtrusiveness on 7-point Likert scale (1 = strongly disagree to 7 = strongly agree)
Usability as measured by participant's report of any technical problems experienced with the intervention website
Usability as measured by participant's report of interest in future usage of the intervention
Usefulness as measured by participant's report of a series of items designed to measure perceived usefulness on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Satisfaction as measured by participant's report of a series of items designed to measure perceived satisfaction on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Satisfaction as measured by participant's report on the Client Satisfaction Questionnaire (CSQ-8)
The Client Satisfaction Questionnaire (CSQ-8) will further be used and adapted to assess satisfaction. The CSQ-8 consists of eight items which are rated on 5-point Likert scale. The CSQ-8 will be adapted for this study by substituting 'service' with 'help" and "program" with "iWAWA" in all items.
Credibility as measured by participant's report on the first 4 items of Credibility/ Expectancy Questionnaire (CEQ)
The Credibility/ Expectancy Questionnaire (CEQ) is a 6-item widely applied measure of the expectancies or perception of intervention credibility and will be adapted for the use in this study.
Women's perspectives and experiences as measured by semi-structured interviews
Engagement as measured by the duration of intervention coach calls
Usability as measured by participant's report of hypothetical recommendation of the intervention to others.

Secondary Outcome Measures

Anxiety level as measured by participant's report on the Generalized Anxiety Disorder Scale (GAD-7)
The Generalized Anxiety Disorder Scale (GAD-7) is a seven-item anxiety measure and items are rated on 4-point Likert-scale ranging from 0' (not at all) to '3' (nearly every day).
Depression, anxiety and stress symptomatology as measured by participant's report on the Depression, Anxiety, and Stress Scale (DASS 21)
The Depression, Anxiety, and Stress Scale (DASS 21) is a 21-item self-report measure of current depressive, anxiety, and stress symptoms. Low positive affect, reduced self-esteem and motivation, and a sense of hopelessness is assessed by seven depression items; fearfulness and physiological arousal is assessed by seven anxiety items, and tension, irritability and a low threshold to frustration are measured by seven stress items. Higher scores indicate more severe symptoms.
Anxiety level as measured by participant's report on the Generalized Anxiety Disorder Scale (GAD-7)
The Generalized Anxiety Disorder Scale (GAD-7) is a seven-item anxiety measure and items are rated on 4-point Likert-scale ranging from 0' (not at all) to '3' (nearly every day).
Depression, anxiety and stress symptomatology as measured by participant's report on the Depression, Anxiety, and Stress Scale (DASS 21)
The Depression, Anxiety, and Stress Scale (DASS 21) is a 21-item self-report measure of current depressive, anxiety, and stress symptoms. Low positive affect, reduced self-esteem and motivation, and a sense of hopelessness is assessed by seven depression items; fearfulness and physiological arousal is assessed by seven anxiety items, and tension, irritability and a low threshold to frustration are measured by seven stress items. Higher scores indicate more severe symptoms.
Anxiety level as measured by participant's report on the Generalized Anxiety Disorder Scale (GAD-7)
The Generalized Anxiety Disorder Scale (GAD-7) is a seven-item anxiety measure and items are rated on 4-point Likert-scale ranging from 0' (not at all) to '3' (nearly every day).
Depression, anxiety and stress symptomatology as measured by participant's report on the Depression, Anxiety, and Stress Scale (DASS 21)
The Depression, Anxiety, and Stress Scale (DASS 21) is a 21-item self-report measure of current depressive, anxiety, and stress symptoms. Low positive affect, reduced self-esteem and motivation, and a sense of hopelessness is assessed by seven depression items; fearfulness and physiological arousal is assessed by seven anxiety items, and tension, irritability and a low threshold to frustration are measured by seven stress items. Higher scores indicate more severe symptoms.
Study feasibility as measured by recruitment rate
Study feasibility as measured by eligibility rate
Study feasibility as measured by consent rate
Study feasibility as measured by retention rate
Study feasibility as measured by pre-intervention data collection rate
Study feasibility as measured by pre-intervention data collection completeness
Study feasibility as measured by post-intervention data collection rate
Study feasibility as measured by post-intervention data collection completeness
Study feasibility as measured by 4 week post intervention follow-up data collection rate
Study feasibility as measured by 4 week post intervention follow-up data collection completeness

Full Information

First Posted
April 30, 2015
Last Updated
January 30, 2018
Sponsor
City, University of London
Collaborators
Monash University
search

1. Study Identification

Unique Protocol Identification Number
NCT02434406
Brief Title
Website-Based Self-Help for Women With Anxiety After Childbirth
Official Title
Feasibility of a Web-Based Intervention for Women With Postpartum Anxiety: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
March 26, 2017 (Actual)
Primary Completion Date
August 30, 2017 (Actual)
Study Completion Date
August 30, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
City, University of London
Collaborators
Monash University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study examines the feasibility and acceptability of a web-based intervention program for women with anxiety after childbirth, potential anxiety reduction after the intervention and determines the feasibility of the study design (randomized controlled design) and recruitment for the intervention in this population to inform the protocol (including effect size and study power) for a randomized controlled trial.
Detailed Description
Background: What Am I Worried About (WAWA) is a self-help booklet intervention for women experiencing anxiety after birth based on cognitive-behavioural and mindfulness principles developed in Australia. The WAWA booklet was found to be acceptable, safe, stigma free, feasible, and demonstrated preliminary efficacy in Australia. A web-based version of WAWA for the use in the United-Kingdom (UK) was developed at City University London in collaboration with the intervention development team in Australia. However, before dissemination the web-based version of WAWA (iWAWA) in the UK it is deemed important to evaluate the program. Therefore, this study aims to examine the feasibility, acceptability, and potential efficacy of this web-based intervention program for women with anxiety after childbirth in the UK. The primary objectives of the proposed study are to: conduct a randomized controlled trial and examine the feasibility of web-based treatment program (iWAWA) in terms of engagement and usability. examine user's acceptability of iWAWA in terms of usefulness, satisfaction, and credibility. The secondary objectives of this study are to: obtain initial estimates of anxiety levels and examine potential patient improvement over the course of the intervention and compared to the control group. determine the feasibility of the study by examining recruitment, consent, attrition, follow-up rates, as well as response rates to questionnaires. Method: For this feasibility study, an embedded mixed methods design is employed utilizing both quantitative and qualitative methods to achieve the above stated aims. For the quantitative part, a randomized control trial is conducted. Outcomes are assessed at pre-intervention, throughout the intervention, post-intervention, and 1-month post-intervention. For the qualitative part, semi-structured interviews are used for a more in-depth exploration of acceptability and feasibility of the iWAWA intervention. The interviews with participants are carried out post intervention. Study benefits: Based on the participants' feedback, this study hopes to inform development and adaptation of the investigated web-based intervention. If the interventions acceptability and feasibility is confirmed, the next steps would be to test the intervention efficacy in a stage II randomized control trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety Disorders
Keywords
Anxiety, Anxiety disorders, Mental health, Postpartum period, maternal welfare, internet, intervention studies, feasibility studies, randomized controlled trial, patient acceptance of health care

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
89 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Web-based intervention
Arm Type
Experimental
Arm Description
Participants get access to the web-based intervention and are asked to work through the 8 modules of the intervention within eight weeks. The intervention program sends automated weekly email reminders about the current session. In addition, users are offered weekly optional 30-minute telephone support with a trained intervention coach.
Arm Title
Wait-list control
Arm Type
No Intervention
Arm Description
Participants get standard care and will be offered access to the web-based intervention at 8-weeks post-randomization.
Intervention Type
Behavioral
Intervention Name(s)
internet-What Am I Worried About
Intervention Description
This web-based intervention consists of three sections: 1) Is this for me? 2) Practice 3) Understanding. The three main sections are divided up into nine sessions. Participants will get access to the program for eight weeks and can access the sessions more than once. Sessions are made up of multimedia presentations and worksheets that are completed online.
Primary Outcome Measure Information:
Title
Engagement as measured by the number of log-ins into the web-based intervention
Time Frame
At time of intervention (8 weeks)
Title
Engagement as measured by the duration of log-ins into the web-based intervention
Time Frame
At time of intervention (8 weeks)
Title
Engagement as measured by the total duration of time spent on the web-based intervention
Time Frame
At time of intervention (8 weeks)
Title
Engagement as measured by the time spent on individual pages of the web-based intervention
Time Frame
At time of intervention (8 weeks)
Title
Engagement as measured by the number of intervention coach calls
Time Frame
At time of intervention (8 weeks)
Title
Usability as measured by participant's report of usefulness ("I found this module useful.") of each intervention module on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Time Frame
At time of intervention (8 weeks) after each completed intervention module
Title
Usability as measured by participant's report of clarity ("This module was clear and understandable.") of each intervention module on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Time Frame
At time of intervention (8 weeks) after each completed intervention module
Title
Usability as measured by participant's report of usability on the System Usability Scale (SUS)
Description
The System Usability Scale (SUS) is a 10-item instrument rated on 5-point Likert scale (1 = strongly disagree to 5 = strongly agree) and participants are asked to rate the degree to which they agree with positive and negative descriptions of a program. The SUS will be adapted for this study by replacing 'the system/product' with 'iWAWA' for all items. Higher scores indicate better usability.
Time Frame
Within 2 weeks after the intervention
Title
Usability as measured by participant's report of usability on a series of items designed to measure ease-of-use and unobtrusiveness on 7-point Likert scale (1 = strongly disagree to 7 = strongly agree)
Time Frame
Within 2 weeks after the intervention
Title
Usability as measured by participant's report of any technical problems experienced with the intervention website
Time Frame
Within 2 weeks after the intervention
Title
Usability as measured by participant's report of interest in future usage of the intervention
Time Frame
Within 2 weeks after the intervention
Title
Usefulness as measured by participant's report of a series of items designed to measure perceived usefulness on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Time Frame
Within 2 weeks after the intervention
Title
Satisfaction as measured by participant's report of a series of items designed to measure perceived satisfaction on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Time Frame
Within 2 weeks after the intervention
Title
Satisfaction as measured by participant's report on the Client Satisfaction Questionnaire (CSQ-8)
Description
The Client Satisfaction Questionnaire (CSQ-8) will further be used and adapted to assess satisfaction. The CSQ-8 consists of eight items which are rated on 5-point Likert scale. The CSQ-8 will be adapted for this study by substituting 'service' with 'help" and "program" with "iWAWA" in all items.
Time Frame
Within 2 weeks after the intervention
Title
Credibility as measured by participant's report on the first 4 items of Credibility/ Expectancy Questionnaire (CEQ)
Description
The Credibility/ Expectancy Questionnaire (CEQ) is a 6-item widely applied measure of the expectancies or perception of intervention credibility and will be adapted for the use in this study.
Time Frame
Within 2 weeks after the intervention
Title
Women's perspectives and experiences as measured by semi-structured interviews
Time Frame
Within 8 weeks after the intervention
Title
Engagement as measured by the duration of intervention coach calls
Time Frame
Continuous throughout the 8 week intervention period
Title
Usability as measured by participant's report of hypothetical recommendation of the intervention to others.
Time Frame
Within 2 weeks after the intervention
Secondary Outcome Measure Information:
Title
Anxiety level as measured by participant's report on the Generalized Anxiety Disorder Scale (GAD-7)
Description
The Generalized Anxiety Disorder Scale (GAD-7) is a seven-item anxiety measure and items are rated on 4-point Likert-scale ranging from 0' (not at all) to '3' (nearly every day).
Time Frame
Within 1 week before the intervention
Title
Depression, anxiety and stress symptomatology as measured by participant's report on the Depression, Anxiety, and Stress Scale (DASS 21)
Description
The Depression, Anxiety, and Stress Scale (DASS 21) is a 21-item self-report measure of current depressive, anxiety, and stress symptoms. Low positive affect, reduced self-esteem and motivation, and a sense of hopelessness is assessed by seven depression items; fearfulness and physiological arousal is assessed by seven anxiety items, and tension, irritability and a low threshold to frustration are measured by seven stress items. Higher scores indicate more severe symptoms.
Time Frame
Within 1 week before the intervention
Title
Anxiety level as measured by participant's report on the Generalized Anxiety Disorder Scale (GAD-7)
Description
The Generalized Anxiety Disorder Scale (GAD-7) is a seven-item anxiety measure and items are rated on 4-point Likert-scale ranging from 0' (not at all) to '3' (nearly every day).
Time Frame
Within 1 week after the intervention
Title
Depression, anxiety and stress symptomatology as measured by participant's report on the Depression, Anxiety, and Stress Scale (DASS 21)
Description
The Depression, Anxiety, and Stress Scale (DASS 21) is a 21-item self-report measure of current depressive, anxiety, and stress symptoms. Low positive affect, reduced self-esteem and motivation, and a sense of hopelessness is assessed by seven depression items; fearfulness and physiological arousal is assessed by seven anxiety items, and tension, irritability and a low threshold to frustration are measured by seven stress items. Higher scores indicate more severe symptoms.
Time Frame
Within 1 week after the intervention
Title
Anxiety level as measured by participant's report on the Generalized Anxiety Disorder Scale (GAD-7)
Description
The Generalized Anxiety Disorder Scale (GAD-7) is a seven-item anxiety measure and items are rated on 4-point Likert-scale ranging from 0' (not at all) to '3' (nearly every day).
Time Frame
Within 1 week after the end of the 4 week post-intervention follow-up period
Title
Depression, anxiety and stress symptomatology as measured by participant's report on the Depression, Anxiety, and Stress Scale (DASS 21)
Description
The Depression, Anxiety, and Stress Scale (DASS 21) is a 21-item self-report measure of current depressive, anxiety, and stress symptoms. Low positive affect, reduced self-esteem and motivation, and a sense of hopelessness is assessed by seven depression items; fearfulness and physiological arousal is assessed by seven anxiety items, and tension, irritability and a low threshold to frustration are measured by seven stress items. Higher scores indicate more severe symptoms.
Time Frame
Within 1 week after the end of the 4 week post-intervention follow-up period
Title
Study feasibility as measured by recruitment rate
Time Frame
Within 4 weeks of ending recruitment
Title
Study feasibility as measured by eligibility rate
Time Frame
Within 4 weeks of ending recruitment
Title
Study feasibility as measured by consent rate
Time Frame
Within 4 weeks of ending recruitment
Title
Study feasibility as measured by retention rate
Time Frame
Within 4 weeks of ending data collection
Title
Study feasibility as measured by pre-intervention data collection rate
Time Frame
Within 4 weeks of ending data collection
Title
Study feasibility as measured by pre-intervention data collection completeness
Time Frame
Within 4 weeks of ending data collection
Title
Study feasibility as measured by post-intervention data collection rate
Time Frame
Within 4 weeks of ending data collection
Title
Study feasibility as measured by post-intervention data collection completeness
Time Frame
Within 4 weeks of ending data collection
Title
Study feasibility as measured by 4 week post intervention follow-up data collection rate
Time Frame
Within 4 weeks of ending data collection
Title
Study feasibility as measured by 4 week post intervention follow-up data collection completeness
Time Frame
Within 4 weeks of ending data collection

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women who are within the first 12 months postpartum (at the beginning of the intervention) Aged over 18 Living in England Sufficient knowledge of written and spoken English Access to internet at home Report a score of ≥5 on the Generalized Anxiety Disorder Scale (GAD-7; Spitzer, Kroenke, Williams, & Löwe, 2006) Exclusion Criteria: Still birth or perinatal death of latest baby Latest baby seriously ill Report self-harm or suicidal ideation Currently receiving formal psychotherapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Miriam T Ashford, MS, cand.PhD
Organizational Affiliation
City, University of London
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Susan Ayers, Professor
Organizational Affiliation
City, University of London
Official's Role
Principal Investigator
Facility Information:
Facility Name
City, University of London
City
London
State/Province
Greater London
ZIP/Postal Code
EC1V 0HB
Country
United Kingdom
Facility Name
City University of London
City
London
Country
United Kingdom

12. IPD Sharing Statement

Citations:
Citation
Rowe HJ; Calcagni SC; Galgut S; Michelmore J; Fisher, JRW. Self-management of mild to moderate anxiety in women who have recently given birth: Development and acceptability of a theoretically sound complex intervention. International Journal of Mental Health Promotion 2014 Oct; 16(5): 308-319. doi:10.1080/14623730.2014.964050
Results Reference
background
PubMed Identifier
29678804
Citation
Ashford MT, Olander EK, Rowe H, Fisher JR, Ayers S. Feasibility and Acceptability of a Web-Based Treatment with Telephone Support for Postpartum Women With Anxiety: Randomized Controlled Trial. JMIR Ment Health. 2018 Apr 20;5(2):e19. doi: 10.2196/mental.9106.
Results Reference
derived

Learn more about this trial

Website-Based Self-Help for Women With Anxiety After Childbirth

We'll reach out to this number within 24 hrs